Skip to main content
. 2002 Jun;76(12):6408–6412. doi: 10.1128/JVI.76.12.6408-6412.2002

TABLE 2.

Postexposure prophylaxis of Ebola Zaire virus challengea

Antibody Antibody doseb Time of antibody treatment (h) Day of death Plasma viremia (log PFU/ml)c
KZ52 25 −1 <1.4
25 −1 <1.4
25 −1 <1.4
25 −1 <1.4
25 −1 <1.4
25 +1 2.4
25 +1 3.5
25 +1 4.0
25 +1 3.5
25 +1 9 6.2
25 +6 11 4.3
25 +6 9 2.9
25 +6 9 4.6
25 +6 10 4.8
25 +6 8 5.2
Equine IgG 3 0 <1.4
3 0 <1.4
3 0 <1.4
3 0 <1.4
3 0 <1.4
None n/a n/a 10 4.1
n/a n/a 9 4.3
n/a n/a 9 5.0
n/a n/a 8 4.9
n/a n/a 8 4.9
a

Animals were administered the antibody at the indicated dose before or after challenge. —, animal lived; n/a, not applicable.

b

KZ52 dose is in milligrams per kilogram of body weight; equine IgG dose is in milliliters per kilogram.

c

Plasma viremia was assessed on day 7 postchallenge.